|
1
|
Li D, Yeung SC, Hassan MM, Konopleva M and
Abbruzzese JL: Antidiabetic therapies affect risk of pancreatic
cancer. Gastroenterology. 137:482–488. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Noto H, Goto A, Tsujimoto T and Noda M:
Cancer risk in diabetic patients treated with metformin: A
systematic review and meta-analysis. PLoS One. 7:e334112012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ben Sahra I, Laurent K, Loubat A,
Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le
Marchand-Brustel Y and Bost F: The antidiabetic drug metformin
exerts an antitumoral effect in vitro and in vivo through a
decrease of cyclin D1 level. Oncogene. 27:3576–3586. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Col NF, Ochs L, Springmann V, Aragaki AK
and Chlebowski RT: Metformin and breast cancer risk: A
meta-analysis and critical literature review. Breast Cancer Res
Treat. 135:639–646. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang P, Li H, Tan X, Chen L and Wang S:
Association of metformin use with cancer incidence and mortality: A
meta-analysis. Cancer Epidemiol. 37:207–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Din FV, Valanciute A, Houde VP, Zibrova D,
Green KA, Sakamoto K, Alessi DR and Dunlop MG: Aspirin inhibits
mTOR signaling, activates AMP-activated protein kinase, and induces
autophagy in colorectal cancer cells. Gastroenterology.
142:1504–15.e3. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang LW, Li ZS, Zou DW, Jin ZD, Gao J and
Xu GM: Metformin induces apoptosis of pancreatic cancer cells.
World J Gastroenterol. 14:7192–7198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kisfalvi K, Eibl G, Sinnett-Smith J and
Rozengurt E: Metformin disrupts crosstalk between G protein-coupled
receptor and insulin receptor signaling systems and inhibits
pancreatic cancer growth. Cancer Res. 69:6539–6545. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kato K, Gong J, Iwama H, Kitanaka A, Tani
J, Miyoshi H, Nomura K, Mimura S, Kobayashi M, Aritomo Y, et al:
The antidiabetic drug metformin inhibits gastric cancer cell
proliferation in vitro and in vivo. Mol Cancer Ther. 11:549–560.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Rooij E, Sutherland LB, Liu N,
Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A
signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Masaki T, Tokuda M, Yoshida S, Nakai S,
Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T,
et al: Comparison study of the expressions of myristoylated
alanine-rich C kinase substrate in hepatocellular carcinoma, liver
cirrhosis, chronic hepatitis, and normal liver. Int J Oncol.
26:661–671. 2005.PubMed/NCBI
|
|
14
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Towbin H, Staehelin T and Gordon J:
Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellulose sheets: Procedure and some applications. Proc Natl
Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chua YJ and Cunningham D: Adjuvant
treatment for resectable pancreatic cancer. J Clin Oncol.
23:4532–4537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oettle H, Post S, Neuhaus P, Gellert K,
Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C,
et al: Adjuvant chemotherapy with gemcitabine vs observation in
patients undergoing curative-intent resection of pancreatic cancer:
A randomized controlled trial. JAMA. 297:267–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Komori S, Osada S and Yoshida K: Novel
strategy with gemcitabine for advanced pancreatic cancer. ISRN
Oncol. 2011:9368932011.PubMed/NCBI
|
|
20
|
Vazquez-Martin A, López-Bonetc E, Cufí S,
Oliveras-Ferraros C, Del Barco S, Martin-Castillo B and Menendez
JA: Repositioning chloroquine and metformin to eliminate cancer
stem cell traits in pre-malignant lesions. Drug Resist Updat.
14:212–223. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bodmer M, Becker C, Meier C, Jick SS and
Meier CR: Use of antidiabetic agents and the risk of pancreatic
cancer: A case-control analysis. Am J Gastroenterol. 107:620–626.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu B, Fan Z, Edgerton SM, Deng XS,
Alimova IN, Lind SE and Thor AD: Metformin induces unique
biological and molecular responses in triple negative breast cancer
cells. Cell Cycle. 8:2031–2040. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Poch B, Gansauge F, Schwarz A, Seufferlein
T, Schnelldorfer T, Ramadani M, Beger HG and Gansauge S: Epidermal
growth factor induces cyclin D1 in human pancreatic carcinoma:
Evidence for a cyclin D1-dependent cell cycle progression.
Pancreas. 23:280–287. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Biscardi JS, Maa MC, Tice DA, Cox ME, Leu
TH and Parsons SJ: c-Src-mediated phosphorylation of the epidermal
growth factor receptor on Tyr845 and Tyr1101 is associated with
modulation of receptor function. J Biol Chem. 274:8335–8343. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moschos SJ and Mantzoros CS: The role of
the IGF system in cancer: From basic to clinical studies and
clinical applications. Oncology. 63:317–332. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Naidu KA, Karl RC, Naidu KA and Coppola D:
Antiproliferative and proapoptotic effect of ascorbyl stearate in
human pancreatic cancer cells: Association with decreased
expression of insulin-like growth factor 1 receptor. Dig Dis Sci.
48:230–237. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Min Y, Adachi Y, Yamamoto H, Ito H, Itoh
F, Lee CT, Nadaf S, Carbone DP and Imai K: Genetic blockade of the
insulin-like growth factor-I receptor: A promising strategy for
human pancreatic cancer. Cancer Res. 63:6432–6441. 2003.PubMed/NCBI
|
|
28
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: MiR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin M, Chen W, Huang J, Gao H, Ye Y, Song
Z and Shen X: MicroRNA expression profiles in human colorectal
cancers with liver metastases. Oncol Rep. 25:739–747. 2011.
|
|
30
|
Watanabe A, Tagawa H, Yamashita J, Teshima
K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T,
et al: The role of microRNA-150 as a tumor suppressor in malignant
lymphoma. Leukemia. 25:1324–1334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Srivastava SK, Bhardwaj A, Singh S, Arora
S, Wang B, Grizzle WE and Singh AP: MicroRNA-150 directly targets
MUC4 and suppresses growth and malignant behavior of pancreatic
cancer cells. Carcinogenesis. 32:1832–1839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou L, Qi X, Potashkin JA, Abdul-Karim FW
and Gorodeski GI: MicroRNAs miR-186 and miR-150 down-regulate
expression of the pro-apoptotic purinergic P2X7 receptor
by activation of instability sites at the 3′-untranslated region of
the gene that decrease steady-state levels of the transcript. J
Biol Chem. 283:28274–28286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, Lo
WL and Yu AL: c-Myb is an evolutionary conserved miR-150 target and
miR-150/c-Myb interaction is important for embryonic development.
Mol Biol Evol. 25:2189–2198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang J, Luo N, Luo Y, Peng Z, Zhang T and
Li S: microRNA-150 inhibits human CD133-positive liver cancer stem
cells through negative regulation of the transcription factor
c-Myb. Int J Oncol. 40:747–756. 2012.
|
|
35
|
Webster RJ, Giles KM, Price KJ, Zhang PM,
Mattick JS and Leedman PJ: Regulation of epidermal growth factor
receptor signaling in human cancer cells by microRNA-7. J Biol
Chem. 284:5731–5741. 2009. View Article : Google Scholar
|
|
36
|
Duex JE, Comeau L, Sorkin A, Purow B and
Kefas B: Usp18 regulates epidermal growth factor (EGF) receptor
expression and cancer cell survival via microRNA-7. J Biol Chem.
286:25377–25386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chou YT, Lin HH, Lien YC, Wang YH, Hong
CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, et al: EGFR promotes
lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc
pathway that targets the Ets2 transcriptional repressor ERF. Cancer
Res. 70:8822–8831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Boyerinas B, Park SM, Hau A, Murmann AE
and Peter ME: The role of let-7 in cell differentiation and cancer.
Endocr Relat Cancer. 17:F19–F36. 2010. View Article : Google Scholar
|
|
39
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee YS and Dutta A: The tumor suppressor
microRNA let-7 represses the HMGA2 oncogene. Genes Dev.
21:1025–1030. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Osada H and Takahashi T: let-7 and
miR-17-92: Small-sized major players in lung cancer development.
Cancer Sci. 102:9–17. 2011. View Article : Google Scholar
|
|
42
|
Lan FF, Wang H, Chen YC, Chan CY, Ng SS,
Li K, Xie D, He ML, Lin MC and Kung HF: Hsa-let-7g inhibits
proliferation of hepatocellular carcinoma cells by downregulation
of c-Myc and upregulation of p16INK4A. Int J Cancer.
128:319–331. 2011. View Article : Google Scholar
|
|
43
|
Fu TY, Chang CC, Lin CT, Lai CH, Peng SY,
Ko YJ and Tang PC: Let-7b-mediated suppression of basigin
expression and metastasis in mouse melanoma cells. Exp Cell Res.
317:445–451. 2011. View Article : Google Scholar
|
|
44
|
Schultz J, Lorenz P, Gross G, Ibrahim S
and Kunz M: MicroRNA let-7b targets important cell cycle molecules
in malignant melanoma cells and interferes with
anchorage-independent growth. Cell Res. 18:549–557. 2008.
View Article : Google Scholar : PubMed/NCBI
|
